Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Stock Information
Stemline Therapeutics (NASDAQ: STML) 4:00 PM ET on Jan 20, 2017
Last Price Change Open Day High 52-Week High
0.60  down   (5.455%) 10.40 10.85 14.60
Volume Previous Close Day Low 52-Week Low
2,326,448 11.00 10.28 3.88

Email  Sign up for email alerts

The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by NASDAQ OMX, both third party services, and Stemline Therapeutics does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes.

Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved